Platelets and atherogenesis: Platelet anti-aggregation activity and endothelial protection from tomatoes (Solanum lycopersicum L.) (Review)

Palomo,Iván; Fuentes,Eduardo; Padró,Teresa; Badimon,Lina

doi:10.3892/etm.2012.477

Platelets and atherogenesis: Platelet anti-aggregation activity and endothelial protection from tomatoes (Solanum lycopersicum L.) (Review)

Authors:
- Iván Palomo
- Eduardo Fuentes
- Teresa Padró
- Lina Badimon
View Affiliations

Affiliations: Department of Clinical Biochemistry and Immunohematology, Faculty of Health Sciences, University of Talca, Talca, Chile, Cardiovascular Research Center (CSIC-ICCC), Hospital de la Santa Creu i Sant Pau-Instituto de Investigación Biomédica Sant Pau, CiberOBENU, Instituto Carlos III, Barcelona, Spain
Published online on: February 9, 2012 https://doi.org/10.3892/etm.2012.477
Pages: 577-584

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

In recent years, it has been shown that platelets are not only involved in the arterial thrombotic process, but also that they play an active role in the inflammatory process of atherogenesis from the beginning. The interaction between platelets and endothelial cells occurs in two manners: activated platelets unite with intact endothelial cells, or platelets in resting adhere to activated endothelium. In this context, inhibition of the platelet function (adhesion/aggregation) could contribute to the prevention of atherothrombosis, the leading cause of cardiovascular morbidity. This can be achieved with antiplatelet agents. However, at the public health level, the level of primary prevention, a healthy diet has also been shown to exert beneficial effects. Among those elements of a healthy diet, the consumption of tomatoes (Solanum lycopersicum L.) stands out for its effect on platelet anti-aggregation activity and endothelial protection, which may be beneficial for cardiovascular health. This article briefly discusses the involvement of platelets in atherogenesis and the possible mechanisms of action provided by tomatoes for platelet anti-aggregation activity and endothelial protection.

View Figures

View References

1.	World Health Organization: Informe sobre la salud en el mundo. Technical Report.WHO; Geneva, Switzerland: 2002
2.	Jackson CF and Wenger NK: Cardiovascular disease in the elderly. Rev Esp Cardiol. 64:697–712. 2011.PubMed/NCBI
3.	Palomo I, Toro C and Alarcón M: The role of platelets in the pathophysiology of atherosclerosis (Review). Mol Med Rep. 1:179–184. 2008.PubMed/NCBI
4.	Palomo I, Alarcón M, Moore-Carrasco R and Argilés J: Hemostasis alterations in metabolic syndrome (Review). Int J Mol Med. 18:969–974. 2006.PubMed/NCBI
5.	Palomo I, Torres G, Alarcon M, Maragaño P, Leiva E and Mujica V: Alta prevalencia de factores de riesgo cardiovascular clásicos en una población de estudiantes universitarios de la región centro-sur de Chile. Rev Esp Cardiol. 59:1099–1105. 2006.PubMed/NCBI
6.	Palomo I, Icaza G, Mujica V, et al: Prevalencia de factores de riesgo cardiovascular clásicos en población adulta de Talca, Chile, 2005. Rev Med Chile. 135:904–912. 2007.PubMed/NCBI
7.	Lubos E, Handy D and Loscalzo J: Role of oxidative stress and nitric oxide in atherothrombosis. Front Biosci. 13:5323–5344. 2009.PubMed/NCBI
8.	Badimón L, Vilahur G and Padró T: Lipoproteínas, plaquetas y aterotrombosis. Rev Esp Cardiol. 62:1161–1178. 2009.
9.	Roldán I: Nuevos antiagregantes en el síndrome coronario agudo. El futuro es hoy Rev Esp Cardiol Suppl. 10:12D–22D. 2010.
10.	Santos M, Aranda E, Vallés J and Palomo I: Hemostasia primaria. Hematología: Fisiopatología y Diagnóstico. Palomo I, Pereira J and Palma J: Editorial Universidad de Talca; Talca: pp. 459–492. 2005
11.	Zhang J, Blackmore PF, Hargrave BY, Xiao S, Beebe SJ and Schoenbach KH: Nanosecond pulse electric field (nanopulse): a novel non-ligand agonist for platelet activation. Arch Biochem Biophys. 471:240–248. 2008. View Article : Google Scholar : PubMed/NCBI
12.	Panes O, Matus V, Sáez CG, Quiroga T, Pereira J and Mezzano D: Human platelets synthesize and express functional tissue factor. Blood. 109:5242–5250. 2007. View Article : Google Scholar : PubMed/NCBI
13.	Aukrust P, Halvorsen B, Ueland T, et al: Activated platelets and atherosclerosis. Expert Rev Cardiovasc Ther. 8:1297–1307. 2010. View Article : Google Scholar
14.	Dauchet L, Amouyel P, Hercberg S and Dallongeville J: Fruit and vegetable consumption and risk of coronary heart disease: a meta-analysis of cohort studies. J Nutr. 136:2588–2593. 2006.PubMed/NCBI
15.	Koleckar V, Brojerova E, Rehakova Z, et al: In vitro antiplatelet activity of flavonoids from Luzea carthamoides. Drug Chem Toxicol. 31:27–35. 2008. View Article : Google Scholar : PubMed/NCBI
16.	Khan AN, Fatima I, Khaliq UA, Malik A, Miana GA, Qureshi ZU and Rasheed H: Potent anti-platelet constituents from Centaurea iberica. Molecules. 16:2053–2064. 2011. View Article : Google Scholar : PubMed/NCBI
17.	Palomo I, Moore-Carrasco R, Carrasco G, Villalobos P and Guzmán L: El consumo de tomates previene el desarrollo de enfermedades cardiovasculares y cáncer: antecedentes epidemiológicos y mecanismos de acción. Idesia. 28:121–129. 2010.
18.	Silverstein R: Inflammation, atherosclerosis, and arterial thrombosis: role of the scavenger receptor CD36. Cleve Clin J Med. 76:S27–S30. 2009. View Article : Google Scholar : PubMed/NCBI
19.	Nesbitt WS, Westein E, Tovar-Lopez FJ, et al: A shear gradient-dependent platelet aggregation mechanism drives thrombus formation. Nat Med. 15:665–673. 2009. View Article : Google Scholar : PubMed/NCBI
20.	Lindemann S, Kramer B, Seizer P and Gawaz M: Platelets, inflammation and atherosclerosis. J Thromb Haemost. 5:203–211. 2007. View Article : Google Scholar
21.	Cimmino G, D’Amico C, Vaccaro V, D’Anna M and Golino P: The missing link between atherosclerosis, inflammation and thrombosis: is it tissue factor? Expert Rev Cardiovasc Ther. 9:517–523. 2011. View Article : Google Scholar : PubMed/NCBI
22.	Verhamme P and Hoylaerts M: The pivotal role of the endothelium in haemostasis and thrombosis. Acta Clinica Belgica. 61:213–219. 2006. View Article : Google Scholar : PubMed/NCBI
23.	Rau JC, Beaulieu LM, Huntington JA and Church FC: Serpins in thrombosis, hemostasis and fibrinolysis. J Thromb Haemost. 5:102–115. 2007. View Article : Google Scholar : PubMed/NCBI
24.	Van Gils J, Zwaginga J and Hordijk P: Molecular and functional interactions among monocytes, platelets, and endothelial cells and their relevance for cardiovascular diseases. J Leukoc Biol. 85:195–204. 2009.PubMed/NCBI
25.	Palomo I, Torres C, Moore-Carrasco R, Alarcón M and Maragaño P: Platelet anti-aggregants: mechanisms of action and use-associated risks. Vitae. 16:133–143. 2009.
26.	Schober A: Chemokines in vascular dysfunction and remodeling. Arterioscler Thromb Vasc Biol. 28:1950–1959. 2008. View Article : Google Scholar : PubMed/NCBI
27.	Badimón JJ, Santos-Gallego C, Torres F, Castillo J and Kaski J: Nuevas herramientas en la estratificación del riesgo cardiovascular. Rev Esp Cardiol Suppl. 11(B): 21–28. 2011.
28.	Lievens D, Zernecke A, Seijkens T, et al: Platelet CD40L mediates thrombotic and inflammatory processes in atherosclerosis. Blood. 116:4317–4327. 2010. View Article : Google Scholar : PubMed/NCBI
29.	Martín M, Rodríguez I, Palacín M and Coto E: Polimorfismos de metaloproteasas y válvula aórtica bicúspide. Rev Esp Cardiol. 63:1382–1389. 2010.
30.	Lievens D, Eijgelaar WJ, Biessen EA, Daemen MJ and Lutgens E: The multi-functionality of CD40L and its receptor CD40 in atherosclerosis. Thromb Haemost. 102:206–214. 2009.PubMed/NCBI
31.	Giannini S, Falcinelli E, Bury L, Guglielmini G, Rossi R, Momi S and Gresele P: Interaction with damaged vessel wall in vivo in humans induces platelets to express CD40L resulting in endothelial activation. No effect of aspirin intake. Am J Physiol Heart Circ Physiol. 300:2072–2079. 2011.
32.	Gleissner C, Von Hundelshausen P and Ley K: Platelet chemokines in vascular disease. Arterioscler Thromb Vasc Biol. 28:1920–1927. 2008. View Article : Google Scholar
33.	Totani L and Evangelista V: Platelet-leukocyte interactions in cardiovascular disease and beyond. Arterioscler Thromb Vasc Biol. 30:2357–2361. 2010. View Article : Google Scholar : PubMed/NCBI
34.	Semple J, Italiano J and Freedman J: Platelets and the immune continuum. Nat Rev Immunol. 11:264–274. 2011. View Article : Google Scholar : PubMed/NCBI
35.	Siegel-Axel D and Gawaz M: Platelets and endothelial cells. Semin Thromb Hemost. 33:128–135. 2007. View Article : Google Scholar
36.	Von Hundelshausen P and Weber C: Platelets as immune cells: bridging inflammation and cardiovascular disease. Circ Res. 100:27–40. 2007.PubMed/NCBI
37.	Badimon L, Storey R and Vilahur G: Update on lipids, inflammation and atherothrombosis. Thromb Haemost. 105:S34–S42. 2011. View Article : Google Scholar : PubMed/NCBI
38.	Zineh I, Beitelshees AL, Welder GJ, et al: Epithelial neutrophilactivating peptide (ENA-78), acute coronary syndrome prognosis, and modulatory effect of statins. PLoS One. 3:1–9. 2008. View Article : Google Scholar : PubMed/NCBI
39.	Zernecke A, Shagdarsuren E and Weber C: Chemokines in atherosclerosis. Arterioscler Thromb Vasc Biol. 28:1897–1908. 2008. View Article : Google Scholar
40.	An G, Wang H, Tang R, et al: P-Selectin glycoprotein ligand-1 is highly expressed on Ly-6Chi monocytes and a major determinant for Ly-6Chi monocyte recruitment to sites of atherosclerosis in mice. Circulation. 117:3227–3237. 2008. View Article : Google Scholar : PubMed/NCBI
41.	Cha BY, Shi WL, Yonezawa T, Teruya T, Nagai K and Woo JT: An inhibitory effect of chrysoeriol on platelet-derived growth factor (PDGF)-induced proliferation and PDGF receptor signaling in human aortic smooth muscle cells. J Pharmacol Sci. 110:105–110. 2009. View Article : Google Scholar : PubMed/NCBI
42.	Vestweber D, Broermann A and Schulte D: Control of endothelial barrier function by regulating vascular endothelial-cadherin. Curr Opin Hematol. 17:230–236. 2010. View Article : Google Scholar : PubMed/NCBI
43.	Komarova Y and Malik A: Regulation of endothelial permeability via paracellular and transcellular transport pathways. Annu Rev Physiol. 72:463–493. 2010. View Article : Google Scholar : PubMed/NCBI
44.	Rojas A and Morales-Segura M: Nitric oxide, an iceberg in cardiovascular physiology: far beyond vessel tone control. Arch Med Res. 35:1–11. 2004. View Article : Google Scholar : PubMed/NCBI
45.	Jennings L: Mechanisms of platelet activation: need for new strategies to protect against platelet-mediated atherothrombosis. Thromb Haemost. 102:248–257. 2009.PubMed/NCBI
46.	Badimon L and Martínez-González J: Disfunción endotelial. Rev Esp Cardiol Suppl. 6:21A–30A. 2006.PubMed/NCBI
47.	Badimon L, Martinez-Gonzalez J, Llorente-Cortes V, Rodriguez C and Padro T: Cell biology and lipoproteins in atherosclerosis. Curr Mol Med. 6:439–456. 2006. View Article : Google Scholar
48.	Deanfield J, Halcox J and Rabelink T: Endothelial function and dysfunction: testing and clinical relevance. Circulation. 115:1285–1295. 2007.PubMed/NCBI
49.	Martinez-Gonzalez J and Badimon L: Influence of statin use on endothelial function: from bench to clinics. Curr Pharm Des. 13:1771–1786. 2007. View Article : Google Scholar : PubMed/NCBI
50.	Palomo I, Moore-Carrasco R, Alarcon M, Rojas A, Espana F, Andres V and Gonzalez-Navarro H: Pathophysiology of the proatherothrombotic state in the metabolic syndrome. Front Biosci. 2:194–208. 2010. View Article : Google Scholar : PubMed/NCBI
51.	Matsumoto T, Kobayashi T and Kamata K: Role of lysophosphatidylcholine (LPC) in atherosclerosis. Curr Med Chem. 14:3209–3220. 2007. View Article : Google Scholar : PubMed/NCBI
52.	Erdogan A, Schaefer MB, Kuhlmann CR, et al: Activation of Ca²⁺ activated potassium channels is involved in lysophosphatidylcholine-induced monocyte adhesion to endothelial cells. Atherosclerosis. 190:100–105. 2007.
53.	Zou Y, Kim CH, Chung JH, et al: Upregulation of endothelial adhesion molecules by lysophosphatidylcholine. Involvement of G protein-coupled receptor GPR4. FEBS J. 274:2573–2584. 2007. View Article : Google Scholar : PubMed/NCBI
54.	Kim EA, Kim JA, Park MH, Jung SC, Suh SH, Pang MG and Kim YJ: Lysophosphatidylcholine induces endothelial cell injury by nitric oxide production through oxidative stress. J Matern Fetal Neonatal Med. 22:325–331. 2009. View Article : Google Scholar : PubMed/NCBI
55.	Barbaux S, Poirier O, Pincet F, Hermand P, Tiret L and Deterre P: The adhesion mediated by the P-selectin P-selectin glycoprotein ligand-1 (PSGL-1) couple is stronger for shorter PSGL-1 variants. J Leukoc Biol. 87:727–734. 2010. View Article : Google Scholar : PubMed/NCBI
56.	Ruggeri Z and Mendolicchio L: Adhesion mechanisms in platelet function. Circ Res. 100:1673–1685. 2007. View Article : Google Scholar : PubMed/NCBI
57.	Lu D, Scully M, Kakkar V and Lu X: ADAM-15 disintegrin-like domain structure and function. Toxins. 2:2411–2427. 2010. View Article : Google Scholar : PubMed/NCBI
58.	Charrier-Hisamuddin L, Laboisse C and Merlin D: ADAM-15: a metalloprotease that mediates inflammation. FASEB J. 22:641–653. 2008. View Article : Google Scholar : PubMed/NCBI
59.	Badimon L and Vilahur G: Platelets, arterial thrombosis and cerebral ischemia. Cerebrovasc Dis. 24:30–39. 2007. View Article : Google Scholar
60.	World Health Organization: Joint WHO/FAO Expert Consultation on Diet, Nutrition, and the Prevention of Chronic Diseases. WHO; Geneva, Switzerland: 2003
61.	He FJ, Nowson CA, Lucas M and MacGregor GA: Increased consumption of fruit and vegetables is related to a reduced risk of coronary heart disease: meta-analysis of cohort studies. J Hum Hypertens. 21:717–728. 2007. View Article : Google Scholar : PubMed/NCBI
62.	Iqbal R, Anand S, Ounpuu S, et al: Dietary patterns and the risk of acute myocardial infarction in 52 countries: results of the INTERHEART study. Circulation. 118:1929–1937. 2008. View Article : Google Scholar : PubMed/NCBI
63.	Carlsen MH, Halvorsen BL, Holte K, et al: The total antioxidant content of more than 3100 foods, beverages, spices, herbs and supplements used worldwide. Nutr J. 9:1–11. 2010. View Article : Google Scholar : PubMed/NCBI
64.	Lako J, Trenerry V, Wahlqvist M, Wattanapenpaiboon N, Sotheeswaran S and Premier R: Phytochemical flavonols, carotenoids and the antioxidant properties of a wide selection of Fijian fruit, vegetables and other readily available foods. Food Chem. 101:1727–1741. 2007. View Article : Google Scholar
65.	Badimon L, Vilahur G and Padro T: Nutraceuticals and atherosclerosis: human trials. Cardiovasc Ther. 28:202–215. 2010. View Article : Google Scholar : PubMed/NCBI
66.	Badimon L and Vilahur G: Enfermedad aterotrombótica coronaria: avances en el tratamiento antiplaquetario. Rev Esp Cardiol. 61:501–513. 2008.
67.	Palomo I, Gutiérrez M, Astudillo L, et al: Efecto antioxidante de frutas y hortalizas de la zona central de Chile. Rev Chil Nutr. 36:152–158. 2009. View Article : Google Scholar
68.	Dauchet L, Péneau S, Bertrais S, et al: Relationships between different types of fruit and vegetable consumption and serum concentrations of antioxidant vitamins. Br J Nutr. 100:633–641. 2008. View Article : Google Scholar
69.	Palomo I, Yuri J, Moore-Carrasco R, Quilodrán A and Neira A: El consumo de manzanas contribuye a prevenir el desarrollo de enfermedades cardiovasculares y cáncer: antecedentes epidemiológicos y mecanismos de acción. Rev Chil Nutr. 37:377–385. 2010.
70.	Pierre S, Crosbie L and Duttaroy A: Inhibitory effect of aqueous extracts of some herbs on human platelet aggregation in vitro. Platelets. 16:469–473. 2005. View Article : Google Scholar : PubMed/NCBI
71.	Torres-Urrutia C, Guzmán L, Schmeda-Hirschmann G, et al: Antiplatelet, anticoagulant, and fibrinolytic activity in vitro of extracts from selected fruits and vegetables. Blood Coagul Fibrinolysis. 22:197–205. 2011. View Article : Google Scholar : PubMed/NCBI
72.	Nuez F: El cultivo del tomate. Editorial Mundi-Prensa; Barcelona: pp. 16–20. 1995
73.	Mekhfi H, Gadi D, Bnouham M, Ziyyat A, Legssyer A and Aziz M: Effect of argan oil on platelet aggregation and bleeding time: a beneficial nutritional property. J Complement Integr Med. 5:1–18. 2008. View Article : Google Scholar
74.	Palomo I, Fuentes E, Carrasco G, González D and Moore-Carrasco R: Actividad antioxidante, hipolipemiante y antiplaquetaria del tomate (Solanum lycopersicum L.), y el efecto de su procesamiento y almacenaje. Rev Chil Nutr. 37:524–533. 2010. View Article : Google Scholar
75.	Dutta-Roy A, Crosbie L and Gordon M: Effects of tomato extract on human platelet aggregation in vitro. Platelets. 12:218–227. 2001. View Article : Google Scholar : PubMed/NCBI
76.	Lazarus S, Dutta-Roy A and Garg M: Aqueous tomato extract inhibits platelet aggregation. Asia Pac J Clin Nutr. 11(Suppl): S2402002.
77.	Yamamoto J, Taka T, Yamada K, et al: Tomatoes have natural anti-thrombotic effects. Br J Nutr. 90:1031–1038. 2003. View Article : Google Scholar : PubMed/NCBI
78.	Fuentes E, Astudillo L, Gutiérrez M, et al: Fractions of aqueous and methanolic extracts from tomato (Solanum lycopersicum L.) present platelet antiaggregant activity. Blood Coagul Fibrinolysis. 23:109–117. 2012. View Article : Google Scholar : PubMed/NCBI
79.	Lazarus S and Garg M: Tomato extract inhibits human platelet aggregation in vitro without increasing basal cAMP levels. Int J Food Sci Nutr. 55:249–256. 2004. View Article : Google Scholar : PubMed/NCBI
80.	O’Kennedy N, Crosbie L, van Lieshout M, Broom JI, Webb DJ and Duttaroy AK: Effects of antiplatelet components of tomato extract on platelet function in vitro and ex vivo: a time-course cannulation study in healthy humans. Am J Clin Nutr. 84:570–579. 2006.PubMed/NCBI
81.	O’Kennedy N, Crosbie L, Whelan S, et al: Effects of tomato extract on platelet function: a double-blinded crossover study in healthy humans. Am J Clin Nutr. 84:561–569. 2006.PubMed/NCBI
82.	Provesi J, Odebrecht C and Amante E: Changes in carotenoids during processing and storage of pumpkin puree. Food Chem. 128:195–202. 2011. View Article : Google Scholar : PubMed/NCBI
83.	Nguyen ML and Schwartz SJ: Lycopene: chemical and biological properties. Food Technol. 58:38–44. 1999.
84.	Shi J and Le M: Lycopene in tomatoes: chemical and physical properties affected by food processing. Crit Rev Biotechnol. 20:293–334. 2000. View Article : Google Scholar : PubMed/NCBI
85.	Agrawal H, Kaul N, Paradkar AR and Mahadik KR: Stability indicating HPTLC determination of clopidogrel bisulphate as bulk drug and in pharmaceutical dosage form. Talanta. 61:581–589. 2003. View Article : Google Scholar : PubMed/NCBI
86.	Lazarus S, Bowen K and Garg M: Tomato juice and platelet aggregation in type 2 diabetes. JAMA. 292:805–806. 2004. View Article : Google Scholar : PubMed/NCBI
87.	Murphy K, Chronopoulos A, Singh I, et al: Dietary flavanols and procyanidin oligomers from cocoa (Theobroma cacao) inhibit platelet function. Am J Clin Nutr. 77:1466–1473. 2003.PubMed/NCBI
88.	Born G and Cross M: The aggregation of blood platelets. J Physiol. 168:178–195. 1963. View Article : Google Scholar : PubMed/NCBI
89.	Unsworth AJ, Smith H, Gissen P, Watson SP and Pears CJ: Submaximal inhibition of protein kinase c restores ADP-induced dense granule secretion in platelets in the presence of Ca²⁺. J Biol Chem. 286:21073–21082. 2011. View Article : Google Scholar : PubMed/NCBI
90.	Kim S, Jin J and Kunapuli S: Akt activation in platelets depends on Gi signaling pathways. J Biol Chem. 279:4186–4195. 2004. View Article : Google Scholar : PubMed/NCBI
91.	Guidetti GF, Bernardi B, Consonni A, Rizzo P, Gruppi C, Balduini C and Torti M: Integrin α2β1 induces phosphorylation-dependent and phosphorylation-independent activation of phospholipase Cγ2 in platelets: role of Src kinase and Rac GTPase. J Thromb Haemost. 7:1200–1206. 2009.
92.	Kim SD, Lee IK, Lee WM, et al: The mechanism of anti-platelet activity of davallialactone: involvement of intracellular calcium ions, extracellular signal-regulated kinase 2 and p38 mitogen-activated protein kinase. Eur J Pharmacol. 584:361–367. 2008. View Article : Google Scholar
93.	Liu FC, Liao CH, Chang YW, Liou JT and Day YJ: A new insight of anti-platelet effects of sirtinol in platelet aggregation via cyclic AMP phosphodiesterase. Biochem Pharmacol. 77:1364–1373. 2009. View Article : Google Scholar : PubMed/NCBI
94.	Ferreiro J, Gómez-Hospital J, Angiolillo D and Cequier A: Los nuevos antagonistas del receptor P2Y12 pueden reemplazar a los inhibidores de la glucoproteína IIb/IIIa? Rev Esp Cardiol Suppl. 11(A): 14–19. 2011.
95.	Angiolillo DJ and Ferreiro JL: Platelet adenosine diphosphate P2Y12 receptor antagonism: benefits and limitations of current treatment strategies and future directions. Rev Esp Cardiol. 63:60–76. 2010.
96.	Olas B, Wachowicz B, Tomczak A, Erler J, Stochmal A and Oleszek W: Comparative anti-platelet and antioxidant properties of polyphenol-rich extracts from: berries of Aronia melanocarpa, seeds of grape and bark of Yucca schidigera in vitro. Platelets. 19:70–77. 2008. View Article : Google Scholar : PubMed/NCBI
97.	Spiel AO, Gilbert JC and Jilma B: Von Willebrand factor in cardiovascular disease: focus on acute coronary syndromes. Circulation. 117:1449–1459. 2008. View Article : Google Scholar : PubMed/NCBI
98.	Fernández-Ortiz A, Núñez-Gil I, Ruiz-Mateos B and Ibáñez B: Propiedades de los diferentes inhibidores de la glucoproteína IIb/ IIIa: se puede aceptar el efecto de clase? Rev Esp Cardiol Supl. 11:3–7. 2011.
99.	Paran E, Novack V, Engelhard YN and Hazan-Halevy I: The effects of natural antioxidants from tomato extract in treated but uncontrolled hypertensive patients. Cardiovasc Drugs Ther. 23:145–151. 2009. View Article : Google Scholar
100.	Silaste ML, Alfthan G, Aro A, Kesäniemi YA and Hörkkö S: Tomato juice decreases LDL cholesterol levels and increases LDL resistance to oxidation. Br J Nutr. 98:1251–1258. 2007. View Article : Google Scholar : PubMed/NCBI
101.	Kim JY, Paik JK, Kim OY, Park HW and Lee JH, Jang Y and Lee JH: Effects of lycopene supplementation on oxidative stress and markers of endothelial function in healthy men. Atherosclerosis. 215:189–195. 2011. View Article : Google Scholar : PubMed/NCBI
102.	Hung CF, Huang TF, Chen BH, Shieh JM, Wu PH and Wu WB: Lycopene inhibits TNF-alpha-induced endothelial ICAM-1 expression and monocyte-endothelial adhesion. Eur J Pharmacol. 586:275–282. 2008. View Article : Google Scholar : PubMed/NCBI
103.	Cavallini C, Trettene M, Degan M, Delva P, Molesini B, Minuz P and Pandolfini T: Anti-angiogenic effects of two cystine-knot miniproteins from tomato fruit. Br J Pharmacol. 162:1261–1273. 2011. View Article : Google Scholar : PubMed/NCBI
104.	Lee D, Grantham R, Mannion J and Trachte A: Carotenoids enhance phosphorylation of Akt and suppress tissue factor activity in human endothelial cells. J Nutr Biochem. 17:780–786. 2006. View Article : Google Scholar : PubMed/NCBI
105.	Palozza P, Simone R, Catalano A, et al: Lycopene prevents 7-ketocholesterol-induced oxidative stress, cell cycle arrest and apoptosis in human macrophages. J Nutr Biochem. 21:34–46. 2010. View Article : Google Scholar : PubMed/NCBI
106.	Santangelo C, Varì R, Scazzocchio B, Di Benedetto R, Filesi C and Masella R: Polyphenols, intracellular signalling and inflammation. Ann Ist Super Sanita. 43:394–405. 2007.PubMed/NCBI
107.	Wood L and Gibson P: Dietary factors lead to innate immune activation in asthma. Pharmacol Ther. 123:37–53. 2009. View Article : Google Scholar : PubMed/NCBI
108.	Tang X, Yang X, Peng Y, Peng Y and Lin J: Protective effects of lycopene against H₂O₂-induced oxidative injury and apoptosis in human endothelial cells. Cardiovasc Drugs Ther. 23:439–448. 2009. View Article : Google Scholar : PubMed/NCBI
109.	Palozza P, Parrone N, Simone R and Catalano A: Lycopene in atherosclerosis prevention: an integrated scheme of the potential mechanisms of action from cell culture studies. Arch Biochem Biophys. 504:26–33. 2010. View Article : Google Scholar : PubMed/NCBI
110.	Simone R, Russo M, Catalano A, Monego G, Froehlich K, Boehm V and Palozza P: Lycopene inhibits Nf-κB-mediated IL-8 expression and changes Redox and PPARγ signalling in cigarette smoke-stimulated macrophages. PLoS One. 6:1–11. 2011.
111.	Stangl V, Kuhn C, Hentschel S, et al: Lack of effects of tomato products on endothelial function in human subjects: results of a randomised, placebo-controlled cross-over study. Br J Nutr. 105:263–267. 2011. View Article : Google Scholar
112.	McCarty M: Scavenging of peroxynitrite-derived radicals by flavonoids may support endothelial NO synthase activity, contributing to the vascular protection associated with high fruit and vegetable intakes. Med Hypotheses. 70:170–181. 2008. View Article : Google Scholar
113.	Weseler A and Bast A: Oxidative stress and vascular function: implications for pharmacologic treatments. Curr Hypertens Rep. 12:154–161. 2010. View Article : Google Scholar : PubMed/NCBI
114.	Duran X, Vilahur G and Badimon L: Exogenous in vivo NO-donor treatment preserves p53 levels and protects vascular cells from apoptosis. Atherosclerosis. 205:101–106. 2009. View Article : Google Scholar : PubMed/NCBI
115.	Choi J, Choi Y, Shin S, et al: Dietary flavonoids differentially reduce oxidized LDL-induced apoptosis in human endothelial cells: role of MAPK- and JAK/STAT-signaling. J Nutr. 138:983–990. 2008.